|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.00 HKD | -1.29% |
|
+3.16% | -11.71% |
| 03-05 | JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-05 | Oil Outlook, Values Drive Asian Stock Markets Higher | MT |
Company Valuation: JD Health International Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 402,204 | 159,928 | 200,696 | 113,169 | 84,460 | 138,068 | 138,068 | - |
| Change | - | -60.24% | 25.49% | -43.61% | -25.37% | 63.47% | 0% | - |
| Enterprise Value (EV) 1 | 370,024 | 118,139 | 154,932 | 98,251 | 61,980 | 104,996 | 98,289 | 89,468 |
| Change | - | -68.07% | 31.14% | -36.58% | -36.92% | 69.4% | -6.39% | -8.97% |
| P/E ratio | -16.2x | -143x | 526x | 52.2x | 20x | 29.3x | 23.2x | 19.3x |
| PBR | 7.11x | 3.89x | 4.38x | 2.25x | 1.5x | 2.26x | 2.06x | 1.86x |
| PEG | - | 1.5x | -4x | 0x | 0.2x | 1x | 1.2x | 1x |
| Capitalization / Revenue | 20.8x | 5.21x | 4.29x | 2.11x | 1.45x | 2.18x | 1.58x | 1.39x |
| EV / Revenue | 19.1x | 3.85x | 3.32x | 1.84x | 1.07x | 1.47x | 1.13x | 0.9x |
| EV / EBITDA | 976x | -90.7x | 879x | 106x | 36.6x | 23.7x | 17.6x | 12.9x |
| EV / EBIT | 1,052x | -86.5x | 4,352x | 110x | 41.9x | 26.8x | 19.5x | 14.1x |
| EV / FCF | 101x | 40.4x | 26.4x | 21.6x | - | 16.7x | 15.2x | 10.4x |
| FCF Yield | 0.99% | 2.47% | 3.79% | 4.62% | - | 5.98% | 6.57% | 9.58% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.8 | -0.35 | 0.12 | 0.68 | 1.32 | 1.7 | 1.853 | 2.224 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 19,383 | 30,682 | 46,736 | 53,530 | 58,160 | 73,441 | 87,338 | 99,338 |
| EBITDA 1 | 378.9 | -1,303 | 176.3 | 928.2 | 1,693 | 4,221 | 5,570 | 6,942 |
| EBIT 1 | 351.7 | -1,366 | 35.6 | 894.4 | 1,479 | 3,941 | 5,041 | 6,357 |
| Net income 1 | -17,234 | -1,074 | 380.1 | 2,142 | 4,162 | 5,375 | 5,900 | 7,101 |
| Net Debt 1 | -32,181 | -41,789 | -45,764 | -14,918 | -22,480 | -33,072 | -39,779 | -48,600 |
| Reference price 2 | 126.31 | 50.06 | 63.11 | 35.49 | 26.41 | 43.00 | 43.00 | 43.00 |
| Nbr of stocks (in thousands) | 3,184,367 | 3,194,617 | 3,179,915 | 3,188,615 | 3,198,565 | 3,210,775 | 3,210,775 | - |
| Announcement Date | 29/03/21 | 28/03/22 | 22/03/23 | 20/03/24 | 06/03/25 | 05/03/26 | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.05x | 1.49x | 24.13x | -.--% | 20.36B | |
| 30.49x | 1.73x | 25.49x | -.--% | 10.53B | |
| 16.85x | 0.75x | 7.76x | 2.01% | 6.04B | |
| 17.11x | 1.11x | 7.87x | 2.36% | 4.32B | |
| 19.28x | 1.23x | 8.72x | 3.37% | 4.05B | |
| 16.94x | 1.49x | 8.9x | 5.09% | 3.69B | |
| 18.54x | 0.73x | 6.15x | 3.03% | 3.18B | |
| 31x | - | - | - | 2.11B | |
| 23.5x | 0.72x | 9x | 1.72% | 1.72B | |
| Average | 22.42x | 1.16x | 12.25x | 2.2% | 6.22B | |
| Weighted average by Cap. | 24.52x | 1.34x | 17.51x | 1.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 6618 Stock
- Valuation JD Health International Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition